46 daysTime to First Decision

Medicines, Volume 11, Issue 6

June 2024 - 2 articles

Cover Story: Medicines (ISSN 2305-6320) is an international, peer-reviewed, and open access journal aimed at combining all areas of medical disciplines and subspecialties in one platform. It mainly publishes, but is not limited to, original research papers, case reports, reviews, systematic reviews, brief reports, concepts and opinions on all aspects of basic, clinical, and translational research in relation to human health. The journal will accept manuscripts on medical concepts that include evidence-based medicine and/or alternative medicine. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. Full details must be provided when publishing an experiment so that the results can be reproduced.

Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
You may sign up for email alerts to receive table of contents of newly released issues.
PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (2)

Select all

Case Report

2,686 Views

11 Pages

An Unusual Case of Immune Complex-Mediated Membranoproliferative Glomerulonephritis as Renal Manifestation of Idiopathic Hypereosinophilic Syndrome: A Case Report and Literature Review

Michael Cieza-Terrones,
José C. De La Flor,
Christian Requejo,
Daniel Villa,
Jacqueline Apaza,
Pablo Rodríguez-Doyágüez,
Rocío Zamora,
Carmen Asato-Higa,
David Rivera-Estrella and
Antonio Carrasco-Yalán

Medicines2024, 11(6), 13;https://doi.org/10.3390/medicines11060013

2 June 2024

Background: Idiopathic hypereosinophilic syndrome (IHES) is a disorder characterized by abnormal and persistent peripheral blood hypereosinophilia (eosinophil count ≥ 1.5 × 109/L and ≥10% eosinophils) with duration ≥ 6 months, associat...

Full Article

Article

2,059 Views

10 Pages

Incidence and Outcomes of COVID-19 Vaccine Hypersensitivity Reactions and Success of COVID-19 Vaccine Provocation Tests Post Previous COVID-19 Vaccine Hypersensitivity

Adi Kurniawan,
Sukamto Koesnoe,
Evy Yunihastuti and
Hamzah Shatri

Medicines2024, 11(6), 12;https://doi.org/10.3390/medicines11060012

27 May 2024

Background: The COVID-19 pandemic has led to high mortality rates. There have been reports of hypersensitivity reactions with mild to severe symptoms. The COVID-19 vaccine provocation test is a vaccination protocol for individuals with a history of h...

Full Article

Get Alerted

Add your email address to receive forthcoming issues of this journal.

Medicines - ISSN 2305-6320

Imprint

Download Flyer